Mesco Pharmaceuticals Limited SHARE PRICE [LIVE]

NSE

₹ N/A

BSE

₹N/A

NSE

BSE Click here to view BSE data

Live Chart

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Open:
High:
Low:

MKT Cap:
52-wk High:
52-wk Low:

Prev close:
P/E:
Div yield:

5 MIN 10 MIN 15 MIN 30 MIN 60 MIN 2 HR 1 D 1 WK 1 M

NEUTRAL

MESCOPHARM

Fundamental analysis

What is not working for the company?

Stock

Sector

Sensex

Name	Mar 21	Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in Mesco Pharmaceuticals Limited

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

MESCOPHARM News

Frequently Asked Questions

Can I buy Mesco Pharmaceuticals Limited (MESCOPHARM) shares?

Yes, You can buy Mesco Pharmaceuticals Limited (MESCOPHARM) shares by opening a Demat account with Angel One.

How do I buy Mesco Pharmaceuticals Limited (MESCOPHARM) from Angel One?

Mesco Pharmaceuticals Limited (MESCOPHARM) share can be brought through the following modes:

Direct investment: You can buy Mesco Pharmaceuticals Limited (MESCOPHARM) shares by opening a Demat account with Angel One.
Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Mesco Pharmaceuticals Limited (MESCOPHARM) shares.

About MESCOPHARM

Today's live share price for Mesco Pharmaceuticals Limited is NSE: N/A, BSE: N/A with a current market capitalization of .

Mesco Pharmaceuticals started commercial operations in Jun.'91 by venturing into seed-marketing of bulk drugs and formulations with the objective of later establishing facilities for manufacture of bulk drugs and formulations. It set up a formulation plant to manufacture injectables, syrups, ointments and tablets/capsules. The company in technical partnership with Merz, Germany, introduced two drugs -- Hepa Merz and Viru Merz -- for hepatitis (liver disorder) and herpes respectively. It is now developing drugs for cardio-vascular diseases and Parkinson's disease. Apart from Merz, Mesco has technical agreements with two Chinese companies -- Guilin Pharmaceutical Factory and China Science & Resources Technology Trading Corporation. The company has expanded its marketing network to the CIS, Italy, Germany and Africa. It is setting up a multi-purpose bulk drug plant with sterile technology to manufacture the latest bulk drugs, in technical collaboration with Chementechno, Austria. During 1996-97, the company earned foreign exchange worth Rs 1.25 cr.